Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland
· Delayed Price · Currency is CHF 15.30
-0.94 (-5.79%)
Mar 6, 2026, 5:31 PM CET
Santhera Pharmaceuticals Holding AG Employees
Santhera Pharmaceuticals Holding AG had 79 employees as of December 31, 2024. The number of employees increased by 34 or 75.22% compared to the previous year.
Employees
79
Change (1Y)
34
Growth (1Y)
75.22%
Revenue / Employee
620.46K CHF
Profits / Employee
-829.66K CHF
Market Cap
226.17M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioVersys AG | 29 |
| Molecular Partners AG | 153 |
| Newron Pharmaceuticals | 22 |
| Xlife Sciences AG | 17 |
| Basilea Pharmaceutica AG | 189 |
| Addex Therapeutics | 2 |
Santhera Pharmaceuticals Holding AG News
- 7 days ago - Santhera Announces Proposed Inclusion and Reimbursement of AGAMREE® (Vamorolone) within Spain's National Health System for the Treatment of Duchenne Muscular Dystrophy - Benzinga
- 6 months ago - Santhera Enters into Agreement with Ikris Pharma Network for the Distribution of AGAMREE® (Vamorolone) in India - GlobeNewsWire
- 7 months ago - Santhera Secures Agreement with Uniphar for the Distribution of AGAMREE® (Vamorolone) in five GCC (Gulf Cooperation Council) Countries - GlobeNewsWire
- 1 year ago - Santhera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by Idorsia - GlobeNewsWire
- 1 year ago - Santhera Enters into Supply and Distribution Agreement for AGAMREE® (Vamorolone) with Clinigen Group - GlobeNewsWire
- 1 year ago - Santhera Enters into an Exclusive Distribution Agreement with GENESIS Pharma for AGAMREE® (Vamorolone) in Central and Eastern Europe - GlobeNewsWire